Invictus MD’s Future Harvest Achieves 50% year over year growth in revenue

Posted on Categories: Investor Relations

50% year over year growth in revenue Vancouver, BC, October 7, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that Future Harvest Development Ltd. (“Future Harvest”), of which Invictus MD currently owns 82.5%, has achieved $587,800 in revenue for the three months ended September 2016 compared to $392,366 for the same period in prior year.

Chris Pearson, Chief Revenue Officer of Future Harvest commented, “Our business continues to see tremendous growth. While double digit growth is in line with the growth in the Cannabis space, our ability to outpace this is reflective of the markets
growing demand for research based products specifically designed for use within the consumable market. The nutrients developed by Future Harvest over the past 20 years are now being used exclusively by many facilities across North America. We are committed to the research, development, & distribution of industry leading products. Supported by the acquisition of our new bottling line and several key internal hires, we are in a dynamic position to strengthen our market share in Canada, the USA, and new emerging markets.“

Dan Kriznic, Chief Executive Officer of Invictus MD commented “Future harvest is now fully focused towards becoming a leading contender in the rapidly expanding fertilizer industry. We have moved towards a fully automated production line with our expanded bottling equipment. This new line is capable of producing 40 litres of fertilizer per minute and is flexible for various sizes from 250ml to 4 litres. We have also expanded our production line giving us the capability to bottle anywhere from 10 litres to 1000 litres completely taking care of the needs of both our large commercial growers and our private label partners.”

As previously announced, the Company intends to complete a spin-out of Future Harvest into a newly formed public company (“NewCo”) in January 2017, subject to shareholder and regulatory approval. As part of the spin-out, shareholders of the
Company will receive one share in NewCo for every one share held in Invictus MD.

About Future Harvest Development Ltd.
For over 20 years, Future Harvest has brought innovative products and solutions to the hydroponic and indoor growing industries. Future Harvest’s product lines are available through leading distributors and retailers across North America, the United Kingdom and Europe and include Nutradip, Plantlife Products and Future Harvest Plastics.

Future Harvest has been manufacturing metering and monitoring equipment for over fifteen years. The most popular and industry standard is the Trimeter, made famous because a single glance tells you if your pH, nutrients and temperatures are on target. All Nutradip and SunBlaster products are developed, designed, tested and assembled in Canada.

Plantlife Products consists of 29 proprietary formulas that offer growers the leading
edge in sediment free plant nutrition. Every product has been developed and tested inhouse by Future Harvest’s own plant scientists.

For more information please visit www.futureharvest.com.

About Invictus MD Strategies Corp.
Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential. We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations. The fundamental core of our operations is centered on the vast opportunities within fragmented industries.

Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and
deploying the proper capital to support long-term growth. Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information please visit www.invictus-md.com.

On Behalf of the Board,
Dan Kriznic
Chairman & CEO
604-368-6437

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed spin-out of Future Harvest, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the proposed spin-out of Future Harvest will occur as anticipated, that the Company will obtain all requisite approvals of the spin-out transaction, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed spin-out may not occur as planned; the timing and receipt requisite approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forwardlooking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbour.

Invictus Achieves EBITDA Milestones

Posted on Categories: Investor Relations

Vancouver, BC, August 18th, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) reports that it has issued an aggregate of 1,400,275 common shares to certain shareholders, including directors, officers, and consultants.

A total of 1,139,275 common shares were converted from 113,926 Class A Preferred Shares on a ten to one basis. The common shares were issued as a result of the Company achieving certain EBITDA milestones pursuant to an escrow agreement dated December 19, 2014 and amended on March 8, 2015. Pursuant to the share purchase agreement dated March 4, 2015, with Prestige Worldwide Holdings Inc., 261,000 common shares were issued following the achievement of certain
EBITDA milestones as outlined in the agreement.

About Invictus MD Strategies Corp.
Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential. We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations. The fundamental core of our operations is centered on the vast opportunities within fragmented industries. Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth. Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information please visit www.invictus-md.com.

On Behalf of the Board,

Dan Kriznic

Chairman & CEO

604-368-6437

 

Invictus MD Announces Share Consolidation

Posted on Categories: Investor Relations

Vancouver, BC, March 11, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) announces that it is proceeding with a consolidation of its issued and outstanding share capital on the basis of one post-consolidated common share for every ten pre-consolidated common shares.  No fractional shares will be issued.  Any fractional share will be rounded down to the nearest whole number.

The consolidation is subject to final confirmation by the Canadian Securities Exchange.  It is expected that the post-consolidated common shares will begin trading on the CSE on March 16, 2016. As a result of the consolidation, the 40,334,296 common shares which are currently issued and outstanding will be reduced to approximately 4,033,429 common shares, subject to rounding.

About Invictus MD Strategies Corp.

Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential.  We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations.  The fundamental core of our operations is centered on the vast opportunities within fragmented industries.

Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth.  Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information please visit www.invictus-md.com.

On Behalf of the Board,

Dan Kriznic

Chairman & CEO

604-368-6437

 

Invictus MD’s Edison Vape Co. Receives Prototype and Continues Patent Process

Posted on Categories: Investor Relations

Vancouver, BC, March 9, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its wholly-owned subsidiary, Edison Vape Co. Ltd. (“Edison”) has received pre-production samples of the Edison device and functional testing has been started. Preliminary testing has indicated extremely positive results and has confirmed the effectiveness of the Edison POD system.

In order to bring the best device possible to market, several design and functionality enhancements have been identified and Edison is currently improving some of the molds and tooling. This fine-tuning will delay the expected launch date to the Company’s second quarter, resulting in a substantially better product for consumers. Further details regarding the launch timing will be provided in the coming weeks once the design enhancements have been completed.

Ryan Selby, CEO of Edison, commented, “The initial working prototype has exceeded our expectations in terms of performance and versatility, and in order to provide the best possible device to consumers, we have identified a number of practical improvements which are being implemented now. We are currently in the process of updating the required molds and tooling, and we look forward to receiving the next round of pre-production samples within the next 45-60 days.”

Edison has also filed for US trademark protection for the Edison brand, and is now in the process of completing the Patent Cooperation Treaty (“PCT”) International Patent application based on the priority filing date of April 29th, 2015. The Edison POD system includes a host of innovative and novel features which will provide Edison with a significant competitive advantage over existing vaporization devices, and filing for the PCT Patent will provide many advantages for Edison. The PCT Patent application will extend the deadline to apply for national Patent protection in most foreign countries until October 29th, 2017, preserving our ability to protect the valuable intellectual property on a global scale.

About Edison Vape Co. Ltd.

Edison Vape Co. is engaged in the design, development, patenting, manufacture, and distribution of a new and improved system for vaporization using low cost single-use PODs. The founders of Edison Vape Co. have a combined 13 years of experience designing, developing, patenting, manufacturing, and distributing innovative products and accessories.

About Invictus MD Strategies Corp.

Invictus MD targets companies with proven brands, strong customer focus, and significant growth potential.  We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations.  The fundamental core of our operations is centered on the vast opportunities within fragmented industries.

Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth.  Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information please visit www.invictus-md.com.

On Behalf of the Board,

Dan Kriznic

Chairman & CEO

604-368-6437

Forward-Looking Statements

Cautionary Note Regarding Forward-Looking Statements:  This release includes certain statements and information that may contain forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing of Edison Vape Co.’s initial launch of its vaporizer products, are forward-looking statements and contain forward-looking information.  Generally, forward-looking information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”.  Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, including that Edison Vape Co.’s vaporizer products will be launched as intended and planned, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including the risks that Edison Vape Co. may not launch its vaporizer products by the second  quarter of 2016.  Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.  There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.  Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information.  The Company does not undertake to update any forward-looking statements or forward-looking information that are incorporated by reference herein, except in accordance with applicable securities laws.  We seek safe harbour.